Short
Long
Short
Long
Short
Education
Long
Short
ORCL — Relief Rally Stalls Below Major ResistanceOracle closed at $142.07 on August 20, 2026. The stock has recovered strongly from the $114.50 low, but the rebound was rejected at $159.26 and has now entered a consolidation phase.
The short-term picture is neutral, while the broader daily trend remains bearish. Price is sitting near the 20-day EMA at $142.92, but remains below the 50-day SMA at $146.52, the 100-day SMA at $164.37, and the 200-day SMA at $173.63. TradingView’s broader moving-average rating also remains bearish. TradingView technical summary
RSI is neutral at approximately 48.8, while MACD remains above its signal line. This suggests that some rebound momentum is still present, but buyers have not yet regained control. With a daily ATR near $7.11, volatility remains elevated.
Key resistance levels
- $146.50–$148.70: immediate resistance and 50-day SMA area
- $152.00–$159.26: major supply zone and recent swing high
- $164.40–$173.60: long-term moving-average resistance
Key support levels
- $141.00–$137.40: immediate support zone
- $128.80–$125.00: secondary support
- $120.00–$114.50: major demand zone and structural low
Bullish scenario
A daily close above $148.70 would improve the short-term structure and could trigger a move toward $152.00, followed by $159.26.
A sustained breakout above $159.26 would provide stronger trend-reversal confirmation, opening the way toward $164.40 and potentially $173.60.
Bearish scenario
A daily close below $137.40 would invalidate the immediate recovery attempt and expose $128.80–$125.00.
If that zone fails, the market could revisit $120.00 and the major $114.50 low. A breakdown below $114.50 would confirm the continuation of the broader bearish structure.
Fundamental context
Oracle’s cloud growth remains impressive: FY2026 cloud revenue increased 39%, while remaining performance obligations reached $638 billion. However, the company also reported negative $23.7 billion in free cash flow, reflecting the enormous investment required to expand its AI infrastructure. Oracle FY2026 results
Conclusion
ORCL is attempting to build a base, but the rebound is not yet a confirmed trend reversal. The decisive range is now $137.40–$148.70:
- Above $148.70: bullish recovery gains credibility.
- Above $159.26: broader reversal confirmation.
- Below $137.40: bearish continuation risk returns.
This analysis reflects a personal market view and is not financial advice.
Share your thoughts in the comments section of the title. I'm interested in hearing your opinion on this topic.
Thank you in advance.
Laurent
✅ DL INVEST | Community Leader $MCHP: Wave (5) Completed — False Breakout, Triggers Pullback📉 📉 📉
The semiconductor sector has enjoyed an incredible run, but sophisticated capital tracks when the trend exhausts.
If you are looking for an aggressive momentum pivot to compound capital, Microchip Technology Inc.
#MCHP is presenting a textbook structural short setup.
The daily chart shows a clean, completed macro 5-wave Elliott structure.
Friday's aggressive breakdown volume has officially confirmed a structural bull trap.
1. The Technical Setup: False Breakout & Liquidity Sweep Looking closely at the daily structure price finished its multi-month expansion at Wave (5), briefly sweeping liquidity just above the 105.38 High.
The Trap: MCHP attempted to sustain momentum above the vital 2024 high of 95.25, but completely failed to attract institutional follow-through.
Instead, it formed a massive distribution cluster.
The Confirmation: Friday’s -8.27% liquidation event slammed price straight down to 88.34. In a single daily session, sellers wiped out weeks of grinding price action, plunging straight back below the 95.25 structural floor on massive volume expansion.
The trap has sprung.
2. The Fundamental Catalysts: Re-Rating Premium Valuations.
A technical trap needs macro headwinds to sustain a downward move.
Friday gave us the ultimate fundamental double-whammy: The Sector Overhang: Broadcom's recent guidance data reset expectations regarding the blistering pace of macro #hyperscaler and #AI chip spending.
This removed a core growth catalyst that was keeping high-multiple semiconductor stocks afloat.
The Discount Rate Shift: Friday’s stronger-than-expected US jobs report (172,000 payrolls) effectively crushed immediate hopes for interest rate cuts.
Stocks trading at premium multi-year forward P/E valuations are hyper-sensitive to these macro discount rate changes.
When rate cuts are delayed, high-multiple semi valuations contract rapidly.
🎯 Tactical Short Execution Plan
Because the daily candle closed right at its session lows (88.34), shorting directly into the hole carries near-term execution risk if the broader index attempts a Monday morning relief bounce.
We want to execute on a low-volume retest of the broken floor.
The Entry Zone: Look to establish a short position on a lower-timeframe dead-cat bounce back toward the 91.50 – 93.00 cluster (retesting the breakdown value area).
The Stop Loss (Invalidation): Strict stop placement on a daily close back above 95.25 (the broken 2024 high line).
If the bulls manage to re-claim this level, the bearish thesis is instantly invalidated and we preserve capital.
Take Profit (TP) Target 1: The pink consolidation zone between 80.00 and 83.00.
This marks the peak of the previous Wave (3) cluster and serves as natural structural support.
Take Profit (TP) Target 2: The blue structural liquidity pool down at 68.00 if the tech sector encounters a deeper macro ABC correction.
💬 What's Your View on Semis?
Is MCHP signalling a broader tech rotation, or do you think the dip buyers step back in at the 80s support block?
Drop your targets and perspectives in the comments section below!
If you want to follow the compounding journey and catch updates on this short trade, make sure to hit that Follow button!
(Disclaimer: Not financial advice.
Manage your risk according to your own capital allocation rules.
If you don't have any Rules make them before entering financial markets) MARUTI SUZUKI (NSE: MARUTI)— Chartology & 12-Month Macro outlookChartology & Structural Context
Multi-Year Inverse Head & Shoulders: The long-term weekly chart features a massive Inverse Head & Shoulders base breakout above the ₹9,124 neckline established between 2018–2023.
Measured Macro Targets:
Linear Target: ₹14,500 (already achieved during the recent impulse leg).
Logarithmic Target: 22,000+ (pointing toward significant multi-year upside expansion).
Current Phase (Consolidation): Following a test of the ₹17,197 all-time high, price is currently pulling back into the ₹13,500 – ₹14,500 structural support region.
The stock is building a re-accumulation base, making this an ideal high-level watch for the next structural leg up.
Key Fundamental Drivers (Next 12 Months)
EV Transition (eVX Rollout): Maruti is entering the EV space with its flagship eVX mid-size electric SUV (offering a ~500 km range platform).
Localized battery manufacturing in Gujarat positions them to capture EV market share while maintaining gross margins.
Production Capacity Expansion: The brand recorded an all-time high output of over 23.4 lakh units in FY26. The rollout of the new Kharkhoda, Haryana facility and upcoming Gujarat expansions will add significant annual capacity to serve domestic and export demand.
Export Volume Aggression: With parent Suzuki Motor Corporation utilizing India as its primary global manufacturing hub, Maruti is targeting 400,000+ export units annually, providing a foreign exchange hedge and revenue diversification.
SUV Dominance & Premiumization: Shifts toward higher-margin Utility Vehicles (Fronx, Grand Vitara, Brezza, Victoris) continue to improve average selling prices (ASP) and operating margins relative to entry-level hatchbacks.
This is a structural macro thesis rather than an immediate order trigger.
You could wait for a lower-timeframe consolidation base around the ₹13,500–₹14,000 zone before defining precise risk parameters for the run toward ₹17,200 and ultimate ₹22,000 log targets. On the flip side We could see a strong spurt to ₹15,000 to signal the next bull run. 
Long
COFORGE: Why ₹2,000 Is Supply Absorption, Not a Structural TopRetail investors often panic when a stock retests a major round-number resistance like ₹2,000 multiple times, calling it a dangerous "Triple Top" or "Quadruple Top." But institutional money knows the reality: the more times a level is tested without a major breakdown, the weaker that ceiling becomes!
Coforge isn't suffering from distribution—big smart money is systematically absorbing every single share being dumped under ₹2,020 to build massive long positions before the next explosive trend.
Why the ₹2,000 Ceiling Will Break
Classic Supply Absorption: Instead of crashing, Coforge has printed continuous higher lows off its ₹1,005 base, tightly coiling into an ascending handle directly beneath the ₹2,021 all-time high. Dips are being bought up aggressively!
20-Year Sector Dominance: Plotting the COFORGE / CNXIT ratio reveals that Coforge has consistently outpaced the Nifty IT index for two decades. Institutional capital rotates into Coforge because it generates real sector-leading alpha.
Boardroom Headlines are Just Noise: The media panic surrounding recent board transitions caused temporary retail selling, but major institutional brokerages (including CLSA, Nuvama, and Motilal Oswal) confirmed the core business operations and growth fundamentals remain 100% intact.
Clear Fibonacci Target Levels 📈
A clean weekly closing candle above ₹2,021.2 clears out the remaining overhead limit sell orders, unlocking clear air toward these key Fibonacci extensions:
Target 1: ₹2,588.3 (Immediate Expansion Zone)
Target 2: ₹3,569.5 (1.618 Macro Fib Expansion)
Target 3: ₹4,546.7 (2.618 Macro Trend Target)
Unstoppable Fundamental Engine ⚙️
Game-Changing Encora Acquisition: The $2.39 Billion deal—the largest digital engineering transaction in Indian IT history—brought global private equity power Advent International aboard as a 21% anchor shareholder.
Massive Order Book Visibility: Executable 12-month order backlog expanded over 44% to a record $2.23 Billion, providing multi-year earnings safety.
86%+ AI & Digital Mix: High-margin AI engineering, cloud, and data services dominate revenues, completely insulating Coforge from low-margin legacy IT displacement.
Don't let short-term retail fear trap you out of a classic institutional setup. The multi-touch compression under ₹2,000 is coiling energy for an aggressive macro expansion toward those upper Fibonacci targets! 💎🙌 
Long
Short 
Long
Long
Thermax - Keep on your watchlist THERMAX — Technical View
CMP: ₹3,682
Trend: 🔴 Bearish
Strong correction from ₹5,278; price remains below both falling trendlines.
RSI: ~40 on weekly / ~31 on daily → weak, though daily is near oversold.
Key levels
🟢 Support: ₹3,550–3,600
Next support: ₹3,200–3,300
🔴 Resistance: ₹3,800–4,000
Major resistance: ₹4,350–4,450
Targets if ₹3,550 breaks: ₹3,300 → ₹3,000
Bullish reversal only above: ₹4,000, preferably with volume.
My view: 🔴 SHORT / AVOID
At ₹3,682, I would not take a fresh long. The risk-reward improves only after a confirmed breakout above ₹4,000.
Technical rating: 6.0/10
Bottom line: SHORT bias below ₹4,000; avoid aggressive shorting near ₹3,550 support. A decisive break of ₹3,550 would make the bearish setup considerably stronger. Short 
Long
Long
Price Is Back at the Same 3-Factor Zone. Coincidence or Pattern?Hello Friends, Welcome to RK_Chaarts
Today we are looking into chart of BSE Ltd for Educational Purpose only:
Price Is Back at the Same 3-Factor Zone. Coincidence or Pattern?
Look at this chart closely. Three things are lining up together right now on BSE Ltd:
Price is sitting on the lower line of a long rising channel.
Price is close to the Weekly 50 EMA.
RSI has dropped into the 40-45 zone.
This is not the first time. It has happened four times before – July 2024, March 2025, September 2025, and January 2026. Every single time, the same three things came together, and price moved up from there.
Now it is happening again in September 2026.
Is this a coincidence ? Or is this a pattern the market keeps repeating ?
I am not saying "buy" or "sell" here. This post is only to show you how confluence works. One signal alone means very little. But when price structure, a moving average, and momentum all point to the same zone at the same time, it becomes worth watching closely.
A simple rule I follow – one signal can be noise. Three signals together are rarely noise.
I am not Sebi registered analyst. My studies are for educational purpose only.
Please Consult your financial advisor before trading or investing. I am not responsible for any kinds of your profits and your losses.
Most investors treat trading as a hobby because they have a full-time job doing something else.
However, If you treat trading like a business, it will pay you like a business.
If you treat like a hobby, hobbies don't pay, they cost you...!
Hope this post is helpful to community
Thanks
RK💕
Disclaimer and Risk Warning.
The analysis and discussion provided on in.tradingview.com is intended for educational purposes only and should not be relied upon for trading decisions. RK_Chaarts is not an investment adviser and the information provided here should not be taken as professional investment advice. Before buying or selling any investments, securities, or precious metals, it is recommended that you conduct your own due diligence. RK_Chaarts does not share in your profits and will not take responsibility for any losses you may incur. So Please Consult your financial advisor before trading or investing.
Education
CIPLA | Bearish Reversal Setup — Channel Break Targets The Liqui
By analyzing the 🇮🇳 #CIPLA (Cipla) chart on the 4H timeframe, we can see that the stock is showing early signs of a bearish reversal after a corrective rally into a key supply area. The structure is coiling, and a break of the rising channel would confirm the next move lower.
📊 4H Timeframe
On the 4H, the story starts with an external CHoCH that broke the prior bullish structure and shifted the higher-timeframe character to bearish. From the lows, price then began a corrective rally back up — and along the way it built internal bullish structure (an i CHoCH, followed by i BOS and another i BOS) as it climbed inside a rising channel.
That corrective rally carried price straight into the Flip Zone ( ₹1,475.70 – ₹1,539.45 ) — the former support that now acts as resistance — where it executed a Liquidity Sweep, running the stops above before stalling.
This is the classic setup for a reversal: a corrective rally into a flip zone, a liquidity grab, and now price rolling over. Price is currently trading around ₹1,419.50 . The key structural level to watch is the Internal Protected Low at ₹1,342.75 — as long as it holds, the internal bullish channel is still technically alive, but a decisive break below it (together with a break of the rising channel) confirms the bearish leg and opens the path down toward the sell-side liquidity (SSL) resting at ₹1,167.05 .
🎯 The Bias
My base case leans bearish, but it's conditional on confirmation. Price has rejected from the Flip Zone after a liquidity sweep — a clean bearish signal — but the internal structure won't be broken until price closes below the Internal Protected Low (₹1,342.75) and breaks the rising channel. On that trigger, the draw is toward the SSL at ₹1,167.05. In my view, as long as price stays capped below the Flip Zone (₹1,475.70 – ₹1,539.45), the rejection favours the sellers — but if buyers reclaim that zone with a decisive close, the bearish idea is invalidated and the corrective rally could extend higher within the channel.
📰 Fundamental Backdrop
The technical setup arrives right before a major catalyst. Cipla's board meets on July 23, 2026 to approve its Q1 FY27 results, with an earnings call the same day — flagged across the sector as a key volatility trigger for pharma. The fundamental backdrop is genuinely constructive: Cipla just posted its highest-ever annual revenue of ₹28,000 crore for FY26, with the India business crossing ₹12,500 crore (up 9% YoY) and North America delivering $780 million, and its regulatory picture is improving after the Pithampur Unit 1 received a favorable VAI status from the USFDA — de-risking future US filings. Analysts are broadly positive (consensus "Buy," average target around ₹1,457), and the company is pushing its 'One-India' strategy and complex US generics as growth levers. But there are real risks to respect: US generic pricing pressure persists, margins are expected to hold in a 23–25% range rather than expand, and pharma stocks have historically shown sharp post-earnings swings — Cipla itself has dropped 6%+ on disappointing prints before. Net-net: the fundamentals are solid, but the July 23 result is a binary event that could easily trigger the exact channel break the chart is setting up — making risk management essential into the print.
This analysis will be updated as the market evolves. If this breakdown added value, drop a like 👍 and a comment 💬 to support the work — and share where you see Cipla heading next! Best Regards, BigBeluga 🐳
